Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
Monoisotopic mass
393.114712179
InChI
InChI=1S/C21H19N3O3S/c1-27-20-13-14(24-28(2,25)26)11-12-19(20)23-21-15-7-3-5-9-17(15)22-18-10-6-4-8-16(18)21/h3-13,24H,1-2H3,(H,22,23)
InChI Key
InChIKey=XCPGHVQEEXUHNC-UHFFFAOYSA-N
IUPAC Name
N-{4-[(acridin-9-yl)amino]-3-methoxyphenyl}methanesulfonamide
Traditional IUPAC Name
N-[4-(acridin-9-ylamino)-3-methoxyphenyl]methanesulfonamide
SMILES
COC1=C(NC2=C3C=CC=CC3=NC3=CC=CC=C23)C=CC(NS(C)(=O)=O)=C1
pKa (strongest acidic)
10.82
pKa (Strongest Basic)
8.44
Refractivity
107.69 m3·mol-1
Dược Lực Học :
Amsacrine is an aminoacridine derivative that is a potent intercalating antineoplastic agent. It is effective in the treatment of acute leukemias and malignant lymphomas, but has poor activity in the treatment of solid tumors. It is frequently used in combination with other antineoplastic agents in chemotherapy protocols. It produces consistent but acceptable myelosuppression and cardiotoxic effects.
Cơ Chế Tác Dụng :
Aminoacridine derivative that is a potent intercalating antineoplastic agent. It is effective in the treatment of acute leukemias and malignant lymphomas, but has poor activity in the treatment of solid tumors. It is frequently used in combination with other antineoplastic agents in chemotherapy protocols. It produces consistent but acceptable myelosuppression and cardiotoxic effects. [PubChem]
Amsacrine binds to DNA through intercalation and external binding. It has a base specificity for A-T pairs. Rapidly dividing cells are two to four times more sensitive to amsacrine than are resting cells. Amsacrine appears to cleave DNA by inducing double stranded breaks. Amsacrine also targets and inhibits topoisomerase II. Cytotoxicity is greatest during the S phase of the cell cycle when topoisomerase levels are at a maximum.
Dược Động Học :
▧ Absorption :
Poorly absorbed
▧ Protein binding :
96-98%
▧ Metabolism :
Extensive, primarily hepatic, converted to glutathione conjugate.
▧ Half Life :
8-9 hours
Độc Tính :
Symptoms of overdose include nausea and vomiting, diarrhea, some cardiotoxicity (rarely).
Chỉ Định :
For treatment of acute myeloid leukaemia.
Tương Tác Thuốc :
-
Trastuzumab
Trastuzumab may increase the risk of neutropenia and anemia. Monitor closely for signs and symptoms of adverse events.
Liều Lượng & Cách Dùng :
Liquid - Intravenous
Dữ Kiện Thương Mại
Nhà Sản Xuất
-
Sản phẩm biệt dược : Amekrin
-
Sản phẩm biệt dược : AMSA P-D
-
Sản phẩm biệt dược : Amsidine
-
Sản phẩm biệt dược : Amsidyl